New Delhi, <Insert Date>: Mankind Pharma has announced that veteran actor Rakesh Bedi is the new face of Gas-O-Fast, its fast-acting Ayurvedic antacid brand. The association, unveiled through a new ad film, leans into Bedi’s iconic comic timing and his recent pop-culture resurgence to address what is perhaps the most universal of Indian experiences: eating too much and paying for it.
The campaign is built around a simple, honest truth: Indians will not stop eating food they love, no matter the consequences. Gas-O-Fast’s new positioning, *Khana banane ka nahi, pachane ka solution*, captures exactly that spirit, offering not a warning against indulgence but a reliable fix for the aftermath. With Bedi’s exaggerated, warmly familiar style at the centre, the campaign turns post-meal discomfort into a shared joke rather than a problem, while reinforcing the brand’s promise of quick, effective relief.
At the heart of Gas-O-Fast’s formulation is jeera (cumin), a time-tested Indian remedy for digestive issues delivered in a fast, fizzy, modern format. The brand’s Ayurvedic credentials and its jeera-based identity make it distinct in a market dominated by synthetic antacids, positioning it as the smart choice for contemporary Indians who want relief rooted in Indian wisdom.
“Indians have always had a complicated relationship with food. We celebrate with it, we bond over it and we absolutely refuse to hold back, and then the stomach has its say. Rakesh Bedi captures that truth better than anyone. His comic style is not just funny, it is familiar in a way that cuts across age groups and geographies. With this campaign, we wanted Gas-O-Fast to feel less like a remedy and more like a co-conspirator in every great meal,” said Joy Chatterjee, Vice President and Head of Sales and Marketing for Mankind Consumers Products Private Limited
The choice of Rakesh Bedi is deliberate. His cultural footprint spans multiple generations, from elders who grew up watching his craft to a younger audience that has rediscovered him through memes and viral moments alike. The campaign is designed to speak to both, making digestive wellness a family-wide conversation rather than a niche concern.
Gas-O-Fast has been growing steadily across India’s antacid market. According to IQVIA data, the brand has crossed ₹200 crores in revenue and holds an approximately 12% national market share. In key states, it has made sharp inroads: West Bengal stands at 27%, Uttar Pradesh at 20%, Haryana at 19% and Punjab at 16%.
The new ad film is live across all digital platforms.
https://www.youtube.com/watch?v=Y8041vw0J1E
About Mankind Pharma
Mankind Pharma (BSE: 543904 | NSE: MANKIND) is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices. The company is a leading player in the domestic pharmaceuticals business present across acute and chronic therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, antidiabetic, neuro/CNS, gynecology, VMN and respiratory, among others with a strategy to increase chronic presence going ahead. In the consumer healthcare business, the company operates in the condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories, among others, with several category-leading brands. Following the acquisition of Bharat Serums and Vaccines Limited, Mankind Pharma has further strengthened its leadership in the domestic women’s health segment. Mankind’s distribution network includes a robust field force of 17,700+ professionals, and a reach extending to over five lakh doctors across urban and rural markets. The company has 32 manufacturing facilities in India manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products. Mankind has a consistent track record of product innovation through 6 dedicated R&D facilities backed by more than 730 scientists.
